US3624224A - Novel first aid products - Google Patents

Novel first aid products Download PDF

Info

Publication number
US3624224A
US3624224A US887355A US3624224DA US3624224A US 3624224 A US3624224 A US 3624224A US 887355 A US887355 A US 887355A US 3624224D A US3624224D A US 3624224DA US 3624224 A US3624224 A US 3624224A
Authority
US
United States
Prior art keywords
pad material
material according
local anesthetic
surface active
pad
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US887355A
Inventor
Ling Wei
Robert Marchisotto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of US3624224A publication Critical patent/US3624224A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A61L2300/208Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402Anaestetics, analgesics, e.g. lidocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45Mixtures of two or more drugs, e.g. synergistic mixtures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S206/00Special receptacle or package
    • Y10S206/812Packaged towel
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S206/00Special receptacle or package
    • Y10S206/828Medicinal content
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S602/00Surgery: splint, brace, or bandage
    • Y10S602/904Film-forming bandage material

Definitions

  • novel compositions can be used to treat minor skin wounds, abrasions, burns, and similar first aid problems. They fight infection, relieve pain on contact and generally soothe the injured area. Furthermore, this antiseptic action is effected without a stinging sensation, thus rendering these compositions especially valuable for treating children and pets who are often reluctant to receive commonly used first aid treatments because of their stinging effect. Moreover, shortly after application, these compositions air-dry and deposit an invisible film which prolongs the activity and aids in protecting the injured area from further immediate contamination.
  • These novel compositions broadly comprise aqueous solutions of a germicidal quaternary ammonium compound, a local anesthetic, and a polyoxyethylene-polyoxypropylene block polymer.
  • Germicidal quaternary ammonium compounds are wellknown in the art. They are generally used in the form of their halides and preferably as chlorides.
  • Preferred quaternary ammonium compound for use in the compositions of this invention are the alkylarylether dimethylbenzylammonium chlorides, an example of which is 2-[2-(p-octylcresoxy)ethoxy]ethyl dimethylbenzylammonium chloride, available under the name of methylbenzethonium chloride or l-lyamine X and the corresponding p-octylphenoxy compound available as benzethonium chloride or Hyamine 1622, and the alkyldimethylbenzyl ammonium chlorides available under the name benzalkonium chloride.
  • alkyltrimethyl ammonium chloride such as cetyltrimethylammonium chloride available under the trade name Cetab; alkyldimethylethylammonium halide such as alkenyldimethylethylammonium bromide known under the trade name Onyxide; alkylpyridinium chloride, such as cetylpyridinium chloride; alkylimidazolinium chloride such as alkylhydroxyethylimidazolinium chloride known as Alrosept MB; alkyldimethyldichlorobenzylammonium chloride such as alkyldimethyl-3,4-dichloro benzylammonium chloride known as Tetrosan; acylcolaminoformylmethyl pyridinium chloride available under the name of Emulsept; and alkarylmethylpyridinium chloride such as polyalkulnapthalene methylpyridinium chloride available
  • local anesthetics are a well-known class of materials.
  • the preferred subclass of local anesthetics for use in a composition of this invention are those amino-substituted phenyl esters and amides distinguishable by having a generic name ending in the syllable caine"
  • This class of local anesthetic compounds will be referred to hereinafter as caine-type.
  • Exemplary of these are lidocaine, tetracaine, benzocaine, procaine, cocaine, mepivacaine and bupivacaine. These can be used as the free base or in a form of their pharmaceutically acceptable acid addition salts, particularly as the hydrochloride.
  • Preferred local anesthetics for use in compositions of this invention are tetracaine and lidocaine.
  • Other local anesthetics which are not of the caine-type" can also be used, for example, benzyl alcohol.
  • p0lyoxyethylene-polyoxypropylene block polymers to be used in the composition of this invention are also well known in the art and may be represented by the structural formula:
  • the polyoxyethylene portion of the polymer may vary from as little as l0 percent to as high as 90 percent. The higher the polyoxyethylene percentage, the more water-soluble becomes the total molecule or polymer.
  • the substantially water-soluble polymers in the molecular weight range of between about 5 and about 1 L000 are preferable. These materials are readily available under the trade name Pluronic polyols.
  • a preferred material of this class for use in the compositions of this invention is available under the trade name of Pluronic F68 and has an average molecular weight of about 8350, although it may vary in range between about 6000 and 9000.
  • a and c in the above formula can, for example, each be 72 and b can be 26.
  • Both the antimicrobial quaternary ammonium compounds and the local anesthetics should be present in the aqueous composition of this invention in a range of 0.1 to 2 percent by weight.
  • the polyoxyethylene-polyoxypropylene block polymers should be present in the amount of 2 to l5 percent by weight of the total composition and preferably 3 to 7 percent.
  • the bulk of the composition is of course water.
  • aqueous compositions of this invention can optionally contain, in addition to the above ingredients, other materials to maximize effectiveness.
  • Nonionic polyethenoxy surface active agents such as the well-known polyethenoxy mono-ethers, polyethenoxy monoesters and polyethenoxy mono-amides are advantageously included in the composition of this invention, preferably in an amount of 0.2 to 3 percent by weight of the composition. These nonionic surface active agents provide detergent action to a much greater extent than the free polyoxyethylenepolyoxypropylene block polymer polyols. Such compounds are well known in the art.
  • the preferred class of materials of this type for use in this invention are the polyethenoxy monoethers of alkylphenols as exemplified by polyethenoxy monoisooctylphenylether, available under the trade name Triton X-100.
  • Other suitable nonionic surface active agents are polyoxyethylenesorbitan monooleate, and the corresponding mono-stearate.
  • the composition of this invention also included a humectant such as propylene glycol, glycerine, sorbitol, diethylene glycol or polyethylene glycol. ln addition to their humectant effect, these materials also serve in aiding dissolution or emulsion of the composition of this invention. These materials are desirably employed within the range of about 1 to 10 percent.
  • a humectant such as propylene glycol, glycerine, sorbitol, diethylene glycol or polyethylene glycol.
  • a chelating agent such as ethylenediamine tetraacetic acid (EDTA) can optionally be added to enhance the antibacterial activity of these compositions.
  • EDTA ethylenediamine tetraacetic acid
  • a minor amount (e.g. 3 percent) of isopropanol can be added to impart a medicinal odor.”
  • a small amount (e.g., 0.5 percent) of menthol provides a soothing cool feeling.” Calming an injured child or other patient is a desirable part of first aid treatment.
  • Auxiliary medicaments may be incorporated into the compositions of this invention to broaden the scope of treatment, as for example, the inclusion of a minor amount of chlorothymol to impart fungicidal properties.
  • compositions of this invention can be applied to the injured area in numerous ways. They can be directly applied from a squeeze bottle or dropper, for example, or sprayed on employing an aerosol canister containing a conventional propellant such as the Freons. Alternatively, a swab can be introduced into a container of the formulation and saturated therewith and applied to the injured area. Similarly, the solutions can be applied by means of a handkerchief or other extraneous cloth or tissue. Each of these methods has disadvantages, however, with regard to convenience, hygiene and/or effectiveness.
  • compositions of this invention can be realized in the embodiment of a hermetically sealed packet containing a pad impregnated with these compositions.
  • the pad should be an absorptive sheet preferably made of nonwoven cellulosic material. Nonwoven rayon has been found to be particularly good for this purpose.
  • the packet should be impervious to liquid or vapor and its interior should be inert to the composition of this invention.
  • Such packets are well known in the art and preferably comprises an outer surface of a metal foil such as aluminum whose inner surface is lined with a thermoplastic film such as polyethylene, polyvinyl resin or cellulose acetate as described, for example, in U.S. Pat. No. 3,057,467
  • a laminate having an intermediate layer of paper is an advantageous variation. This sealed packet protects both the composition and the applicator against'contamination occurring after manufacture and before application to the wounded area.
  • the invention in this preferred embodiment furthermore provides a sanitary means to cleanse the wounded area thoroughly of dirt and other particles.
  • a sanitary means to cleanse the wounded area thoroughly of dirt and other particles.
  • it aids in preventing further infection by removal of superficial organisms that have not yet infected the wound, and by prophylaxis of the surrounding area, while at the same time fighting infection by any organisms already in the wound.
  • Use of this pad also permits the application of a thin uniform coating of the composition, thereby minimizing the time necessary for the skin to dry and the film to form.
  • the compositions additionally contain a nonionic polyethenoxy surface active agent as described above to further aid in the cleansing operation.
  • This preferred embodiment provides an ideal means to have the compositions of this invention readily available at the time the injury is sustained since it can be carried in the pocket, handbag, as well as stored on vehicles or at home or work.
  • the entire packet is inexpensive enough to be disposed of after a single use.
  • the open foil packet provides a hygienic place to temporarily store the used pad until suitable disposal facilities become available.
  • EXAMPLE A piece of nonwoven rayon pad measuring 3 inches X 3%inches is folded longitudinally and transversely and is inserted into a pouch formed by two sheets of a laminate of aluminum foil and paper, coated (on the paper'side) with polyethylene. Two milliliters of a formulation consisting of:
  • methylbenzethonium chloride 0.5% telracnine hydrochloride 0.6% polyoxyelhylene-polyoxypropylene 5.0%
  • the pad could alternatively be folded in a zigzag or accordian-pleating" fold.
  • An absorptive nonwoven cellulosic sheet of single use disposable pad material impregnated with a nonstinging antiseptic composition which air-dries and forms a protective and activity-prolonging film coating said composition consisting essentially of an aqueous solution of effective amounts within the range of 0.1-2 percent by weight of each of a germicidal quaternary ammonium halide and a local anesthetic compound, and 2-150 by weight of a water soluble polyoxyethylene-polyoxypropylene block polymer and 0.2-3 percent by weight of a nonionic surface active agent selected from the class consisting of polyethenoxy ethers, polyethenoxy esters and polyethenoxy amides, said disposable pad being of suitabl small dimensions to be folded and filled into a hermetica ly sealed packet that can be earned in the pocket or handbag.
  • a pad material according to claim 1 wherein said local anesthetic compound is of the "caine" type.
  • a pad material according to claim 1 wherein said block polymer has an average molecular weight between about 6000 and 9000.
  • a pad material according to claim 1 wherein said local anesthetic is selected from the group consisting of tetracaine and lidocaine.
  • a method of painlessly forming a thin invisible uniform protective and activity-prolonging film coating on a skin wound comprising applying to said would by means of an absorptive nonwoven cellulosic sheet of single use disposable pad material impregnated in accordance with claim 14, said composition comprising a germicidal quaternary ammonium halide, said local anesthetic, said oxyethylene-oxypropylene block polymer and said nonionic surface active agent.

Abstract

Disclosed herein is a portable disposable first aid pad impregnated with a film-forming composition consisting essentially of specified amounts of germicidal quaternary ammonium halide, a local anesthetic, a water soluble polyoxyethylene-polyoxypropylene block polymer and certain nonionic surface active agents.

Description

United States Patent Inventors Ling Wei Watcbung; Robert Marchisotto, East Brunswick, both of NJ. Appl. No. 887,355 Filed Dec. 22, 1969 Patented Nov. 30, 1971 Assignee Scherlng Corporation Bloomfield, NJ.
NOVEL FIRST AID PRQDU TS 8 Claims, No Drawings US. Cl 424/28, 15/506, 128/156, 128/260, 206/57, 206/63.2,
424/329 A61! 13/00, A611 15/00 Field of Search 424/25, 27, 28, 78, 310, 329; 15/506; 252/106; 206/57, 63.2;
Int.
[56] References Cited UNITED STATES PATENTS 1,353,954 9/1920 Henry... 206/57 2,379,657 7/1945 Ryberg 206/63.2 2,689,814 9/1954 Nicholls 424/195 2,702,780 2/1955 Lerner 424/25 X 2,801,201 7/1957 Kipnis 424/310 X 2,921,885 1/1960 Bouchal 424/54 2,999,265 9/1961 Duane et al.. 15/506 3,138,533 6/1964 Heim 424/25 3,264,188 8/1966 Gresham 424/28 3,283,357 11/1966 Decker et a1. 15/506 3,539,520 11/1970 Cantor et a1 252/106 Primary Examiner-Shep K. Rose Anomeys Stephen B. Coan and Bruce M. Eisen ABSTRACT: Disclosed herein is a portable disposable first aid FIRST AID PRODUCTS This invention relates to novel compositions of matter and to an article incorporating these compositions which uniquely fully exploits all their beneficial properties.
These novel compositions can be used to treat minor skin wounds, abrasions, burns, and similar first aid problems. They fight infection, relieve pain on contact and generally soothe the injured area. Furthermore, this antiseptic action is effected without a stinging sensation, thus rendering these compositions especially valuable for treating children and pets who are often reluctant to receive commonly used first aid treatments because of their stinging effect. Moreover, shortly after application, these compositions air-dry and deposit an invisible film which prolongs the activity and aids in protecting the injured area from further immediate contamination. These novel compositions broadly comprise aqueous solutions of a germicidal quaternary ammonium compound, a local anesthetic, and a polyoxyethylene-polyoxypropylene block polymer.
Germicidal quaternary ammonium compounds are wellknown in the art. They are generally used in the form of their halides and preferably as chlorides. Preferred quaternary ammonium compound for use in the compositions of this invention are the alkylarylether dimethylbenzylammonium chlorides, an example of which is 2-[2-(p-octylcresoxy)ethoxy]ethyl dimethylbenzylammonium chloride, available under the name of methylbenzethonium chloride or l-lyamine X and the corresponding p-octylphenoxy compound available as benzethonium chloride or Hyamine 1622, and the alkyldimethylbenzyl ammonium chlorides available under the name benzalkonium chloride. Other suitable germicidal quaternary ammonium compounds are alkyltrimethyl ammonium chloride, such as cetyltrimethylammonium chloride available under the trade name Cetab; alkyldimethylethylammonium halide such as alkenyldimethylethylammonium bromide known under the trade name Onyxide; alkylpyridinium chloride, such as cetylpyridinium chloride; alkylimidazolinium chloride such as alkylhydroxyethylimidazolinium chloride known as Alrosept MB; alkyldimethyldichlorobenzylammonium chloride such as alkyldimethyl-3,4-dichloro benzylammonium chloride known as Tetrosan; acylcolaminoformylmethyl pyridinium chloride available under the name of Emulsept; and alkarylmethylpyridinium chloride such as polyalkulnapthalene methylpyridinium chloride available under the trade name Emcol. In the foregoing compounds the term alkyl" is understood to encompass C l-l to C I-l radicals including mixtures within this range, this being the range in which quaternary ammonium compounds are considered to have good germicidal activity.
Similarly, local anesthetics are a well-known class of materials. The preferred subclass of local anesthetics for use in a composition of this invention are those amino-substituted phenyl esters and amides distinguishable by having a generic name ending in the syllable caine" This class of local anesthetic compounds will be referred to hereinafter as caine-type. Exemplary of these are lidocaine, tetracaine, benzocaine, procaine, cocaine, mepivacaine and bupivacaine. These can be used as the free base or in a form of their pharmaceutically acceptable acid addition salts, particularly as the hydrochloride. Preferred local anesthetics for use in compositions of this invention are tetracaine and lidocaine. Other local anesthetics which are not of the caine-type" can also be used, for example, benzyl alcohol.
The p0lyoxyethylene-polyoxypropylene block polymers to be used in the composition of this invention are also well known in the art and may be represented by the structural formula:
2 )n( 3 6 )I|( 2 -I )r wherein the (C H O) represents the polyoxypropylene hydrophobic base component and the HO(C H ,O),, and (C H,O)H represent the polyoxyethylene hydrophilic constituents. The polyoxyethylene portion of the polymer may vary from as little as l0 percent to as high as 90 percent. The higher the polyoxyethylene percentage, the more water-soluble becomes the total molecule or polymer. The substantially water-soluble polymers in the molecular weight range of between about 5 and about 1 L000 are preferable. These materials are readily available under the trade name Pluronic polyols. A preferred material of this class for use in the compositions of this invention is available under the trade name of Pluronic F68 and has an average molecular weight of about 8350, although it may vary in range between about 6000 and 9000. in this material a and c in the above formula can, for example, each be 72 and b can be 26.
Both the antimicrobial quaternary ammonium compounds and the local anesthetics should be present in the aqueous composition of this invention in a range of 0.1 to 2 percent by weight. The polyoxyethylene-polyoxypropylene block polymers should be present in the amount of 2 to l5 percent by weight of the total composition and preferably 3 to 7 percent. The bulk of the composition is of course water.
The aqueous compositions of this invention can optionally contain, in addition to the above ingredients, other materials to maximize effectiveness.
Nonionic polyethenoxy surface active agents such as the well-known polyethenoxy mono-ethers, polyethenoxy monoesters and polyethenoxy mono-amides are advantageously included in the composition of this invention, preferably in an amount of 0.2 to 3 percent by weight of the composition. These nonionic surface active agents provide detergent action to a much greater extent than the free polyoxyethylenepolyoxypropylene block polymer polyols. Such compounds are well known in the art. The preferred class of materials of this type for use in this invention are the polyethenoxy monoethers of alkylphenols as exemplified by polyethenoxy monoisooctylphenylether, available under the trade name Triton X-100. Other suitable nonionic surface active agents are polyoxyethylenesorbitan monooleate, and the corresponding mono-stearate.
Desirably, the composition of this invention also included a humectant such as propylene glycol, glycerine, sorbitol, diethylene glycol or polyethylene glycol. ln addition to their humectant effect, these materials also serve in aiding dissolution or emulsion of the composition of this invention. These materials are desirably employed within the range of about 1 to 10 percent.
A chelating agent such as ethylenediamine tetraacetic acid (EDTA) can optionally be added to enhance the antibacterial activity of these compositions.
A minor amount (e.g. 3 percent) of isopropanol can be added to impart a medicinal odor." Similarly, a small amount (e.g., 0.5 percent) of menthol provides a soothing cool feeling." Calming an injured child or other patient is a desirable part of first aid treatment.
Auxiliary medicaments may be incorporated into the compositions of this invention to broaden the scope of treatment, as for example, the inclusion of a minor amount of chlorothymol to impart fungicidal properties.
The compositions of this invention can be applied to the injured area in numerous ways. They can be directly applied from a squeeze bottle or dropper, for example, or sprayed on employing an aerosol canister containing a conventional propellant such as the Freons. Alternatively, a swab can be introduced into a container of the formulation and saturated therewith and applied to the injured area. Similarly, the solutions can be applied by means of a handkerchief or other extraneous cloth or tissue. Each of these methods has disadvantages, however, with regard to convenience, hygiene and/or effectiveness.
As a highly preferred embodiment of this invention, we have found that the maximum benefit of the compositions of this invention can be realized in the embodiment of a hermetically sealed packet containing a pad impregnated with these compositions. The pad should be an absorptive sheet preferably made of nonwoven cellulosic material. Nonwoven rayon has been found to be particularly good for this purpose. The packet should be impervious to liquid or vapor and its interior should be inert to the composition of this invention. Such packets are well known in the art and preferably comprises an outer surface of a metal foil such as aluminum whose inner surface is lined with a thermoplastic film such as polyethylene, polyvinyl resin or cellulose acetate as described, for example, in U.S. Pat. No. 3,057,467 A laminate having an intermediate layer of paper is an advantageous variation. This sealed packet protects both the composition and the applicator against'contamination occurring after manufacture and before application to the wounded area.
The invention in this preferred embodiment furthermore provides a sanitary means to cleanse the wounded area thoroughly of dirt and other particles. Thus, it aids in preventing further infection by removal of superficial organisms that have not yet infected the wound, and by prophylaxis of the surrounding area, while at the same time fighting infection by any organisms already in the wound. Use of this pad also permits the application of a thin uniform coating of the composition, thereby minimizing the time necessary for the skin to dry and the film to form. In this embodiment it is preferred that the compositions additionally contain a nonionic polyethenoxy surface active agent as described above to further aid in the cleansing operation.
This preferred embodiment provides an ideal means to have the compositions of this invention readily available at the time the injury is sustained since it can be carried in the pocket, handbag, as well as stored on vehicles or at home or work. The entire packet is inexpensive enough to be disposed of after a single use. Moreover, the open foil packet provides a hygienic place to temporarily store the used pad until suitable disposal facilities become available.
The following example illustrates a preferred embodiment of this invention.
EXAMPLE A piece of nonwoven rayon pad measuring 3 inches X 3%inches is folded longitudinally and transversely and is inserted into a pouch formed by two sheets of a laminate of aluminum foil and paper, coated (on the paper'side) with polyethylene. Two milliliters of a formulation consisting of:
methylbenzethonium chloride 0.5% telracnine hydrochloride 0.6% polyoxyelhylene-polyoxypropylene 5.0%
(Pluronic F68) polyethenoxy alkylaryl ether 2.0%
(Triton X I) propylene glycol 3.0% isopropyl alcohol 3.0% methanol 0.11
purified water 85.8%
are injected into the folds of the pad and the aluminum laminate is then heat sealed on the open fourth side to complete the packet.
The pad could alternatively be folded in a zigzag or accordian-pleating" fold. Numerous other variations of the above-described nonstinging products and processes that within the spirit of this invention will become apparent to one skilled in the art.
We claim:
1. An absorptive nonwoven cellulosic sheet of single use disposable pad material impregnated with a nonstinging antiseptic composition which air-dries and forms a protective and activity-prolonging film coating, said composition consisting essentially of an aqueous solution of effective amounts within the range of 0.1-2 percent by weight of each of a germicidal quaternary ammonium halide and a local anesthetic compound, and 2-150 by weight of a water soluble polyoxyethylene-polyoxypropylene block polymer and 0.2-3 percent by weight of a nonionic surface active agent selected from the class consisting of polyethenoxy ethers, polyethenoxy esters and polyethenoxy amides, said disposable pad being of suitabl small dimensions to be folded and filled into a hermetica ly sealed packet that can be earned in the pocket or handbag.
2. A pad material according to claim 1 wherein said local anesthetic compound is of the "caine" type.
3. A pad material according to claim 1 wherein said block polymer has an average molecular weight between about 6000 and 9000.
4. A pad material according to claim 1 wherein said local anesthetic is selected from the group consisting of tetracaine and lidocaine.
5. A pad material according to claim 4 wherein said nonionic surface active agent is a polyethenoxy mono-alkylaryl ether.
6. A pad material according to claim I wherein said cellulosic sheet material is rayon.
7. A method of painlessly forming a thin invisible uniform protective and activity-prolonging film coating on a skin wound comprising applying to said would by means of an absorptive nonwoven cellulosic sheet of single use disposable pad material impregnated in accordance with claim 14, said composition comprising a germicidal quaternary ammonium halide, said local anesthetic, said oxyethylene-oxypropylene block polymer and said nonionic surface active agent.
8. A method according to claim 7 wherein said cellulosic sheet material is rayon.
UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION Patent No. 5, 62%, 22 Dated November 50, 19?].
Inventor) Ling Wei and Robert Marchisotto It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:
F. Column 1, lines ML and 1L5, "polyalkulnapthalene" should read polyalklynapthalene Column 1, line 72, (C H O)H" should read (C H O) H Column 3, lines 2 and 5 "comprises" should read comprise Column 5, line +8, "methamof should read menthol Column line 18,
"2-150" should read 2l5/ Column line +1, "said would" should read said wound Signed and sealed this 13th day of June 1972.
(SEAL) Attest:
EDWARD M.FLETCHER, JR. ROBERT GOTTSCHALK Attesting Officer Commissioner of Patents

Claims (7)

  1. 2. A pad material according to claim 1 wherein said local anesthetic compound is of the ''''caine'''' type.
  2. 3. A pad material according to claim 1 wherein said block polymer has an average molecular weight between about 6000 and 9000.
  3. 4. A pad material according to claim 1 wherein said local anesthetic is selected from the group consisting of tetracaine and lidocaine.
  4. 5. A pad material according to claim 4 wherein said nonionic surface active agent is a polyethenoxy mono-alkylaryl ether.
  5. 6. A pad material according to claim 1 wherein said cellulosic sheet material is rayon.
  6. 7. A method of painlessly forming a thin invisible uniform protective and activity-prolonging film coating on a skin wound comprising applying to said wound by means of an absorptive nonwoven cellulosic sheet of single use disposable pad material impregnated in accordance with claim 14, said composition comprising a germicidal quaternary ammonium halide, said local anesthetic, said oxyethylene-oxypropylene block polymer and said nonionic surface active agent.
  7. 8. A method according to claim 7 wherein said cellulosic sheet material is rayon.
US887355A 1969-12-22 1969-12-22 Novel first aid products Expired - Lifetime US3624224A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88735569A 1969-12-22 1969-12-22
US16585771A 1971-06-25 1971-06-25

Publications (1)

Publication Number Publication Date
US3624224A true US3624224A (en) 1971-11-30

Family

ID=26861759

Family Applications (2)

Application Number Title Priority Date Filing Date
US887355A Expired - Lifetime US3624224A (en) 1969-12-22 1969-12-22 Novel first aid products
US00165857A Expired - Lifetime US3730960A (en) 1969-12-22 1971-06-25 Novel first aid products

Family Applications After (1)

Application Number Title Priority Date Filing Date
US00165857A Expired - Lifetime US3730960A (en) 1969-12-22 1971-06-25 Novel first aid products

Country Status (6)

Country Link
US (2) US3624224A (en)
AT (1) AT316739B (en)
BE (1) BE752620A (en)
CA (1) CA949451A (en)
DE (1) DE2031889A1 (en)
GB (1) GB1300588A (en)

Cited By (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3814095A (en) * 1972-03-24 1974-06-04 H Lubens Occlusively applied anesthetic patch
US3902559A (en) * 1972-06-29 1975-09-02 Water Jel Int Pty Ltd Fire fighting appliances
US4259103A (en) * 1979-03-12 1981-03-31 Dow Corning Corporation Method of reducing the number of microorganisms in a media and a method of preservation
US4307143A (en) * 1977-10-17 1981-12-22 Kimberly-Clark Corporation Microfiber oil and water pipe
US4321277A (en) * 1978-12-04 1982-03-23 Research Lab Products, Inc. Germicidal use of compositions containing certain quaternary ammonium compounds
US4340043A (en) * 1978-11-17 1982-07-20 Smith & Nephew Research Ltd. Adhesive-coated sheet material incorporating anti-bacterial substances
US4464293A (en) * 1982-04-12 1984-08-07 Dobrin Robert J Liquid cleaner-disinfectant composition for use in wiping down dental operatories
USRE31885E (en) * 1977-10-17 1985-05-14 Kimberly-Clark Corporation Microfiber oil and water wipe
US4615937A (en) * 1985-09-05 1986-10-07 The James River Corporation Antimicrobially active, non-woven web used in a wet wiper
US4721511A (en) * 1984-10-05 1988-01-26 W. R. Grace & Co. Leach resistant antimicrobial fabric
US4732797A (en) * 1987-02-27 1988-03-22 James River Corporation Wet wiper natural acid preservation system
US4737405A (en) * 1985-09-30 1988-04-12 James River Corporation Binder catalyst for an antimicrobially active, non-woven web
US4740398A (en) * 1985-09-30 1988-04-26 James River Corporation Binder catalyst for an antimicrobially active, non-woven web
US4746509A (en) * 1983-03-24 1988-05-24 Rhone-Poulenc Sante Transdermal medicament
US4781974A (en) * 1986-04-23 1988-11-01 James River Corporation Antimicrobially active wet wiper
US4834076A (en) * 1985-04-17 1989-05-30 Millet Jean M Device for treating the external human epithelium, process for its manufacture and process for using such a device
US4920158A (en) * 1989-10-11 1990-04-24 Medipro Sciences Limited Hydrogel-forming wound dressing or skin coating material
US5013769A (en) * 1988-08-22 1991-05-07 Medipro Sciences Limited Method of making a hydrogel-forming wound dressing or skin coating material
US5286538A (en) * 1991-08-05 1994-02-15 Leonard Pearlstein Disposable container for moist paper towels the same
US5458933A (en) * 1992-10-16 1995-10-17 Leonard Pearlstein Compostable packaging for containment of liquids
US5512333A (en) * 1992-10-16 1996-04-30 Icd Industries Method of making and using a degradable package for containment of liquids
US5540962A (en) * 1992-10-16 1996-07-30 Leonard Pearlstein Degradable package for containment of liquids
US5895504A (en) * 1997-07-09 1999-04-20 S. C. Johnson & Son, Inc. Methods for using a fabric wipe
EP0954312A1 (en) * 1996-08-12 1999-11-10 Bruce Miller Topical composition for burn healing
AU715706B2 (en) * 1996-01-05 2000-02-10 Reckitt Benckiser Healthcare (Uk) Limited Antiseptic composition containing a quaternary ammonium compound a chelating agent and a polyol
WO2000050004A2 (en) * 1999-02-23 2000-08-31 Ioteck, Inc. Surgical anesthesia delivery system
US6364862B1 (en) * 1999-09-17 2002-04-02 Daniel Bonilla Single pad for providing both an anesthetic and an antiseptic for an injection site
US20030165403A1 (en) * 2003-03-12 2003-09-04 Marsden James L. Decontamination of surface exposed to biological warfare agents
US6702925B2 (en) 2000-12-22 2004-03-09 Vibre-Tech Llc Method and apparatus for forming a paper or tissue web
WO2004019682A1 (en) * 2002-08-28 2004-03-11 Luis Buil Torres Pharmaceutical composition for the treatment of viral, fungal and bacterial infections and applications of same
US20040140077A1 (en) * 2001-12-21 2004-07-22 Bricco Michael J. Method and apparatus for forming a paper or tissue web
US6986897B1 (en) 1999-10-04 2006-01-17 Johnson & Johnson Consumer Companies, Inc. Alcohol-free anti-bacterial wipes
US20060052269A1 (en) * 2004-09-01 2006-03-09 Panandiker Rajan K Premoistened disposable wipe
US20060276356A1 (en) * 2004-09-01 2006-12-07 Global General Premoistened wipe
US20060277706A1 (en) * 2004-09-01 2006-12-14 Clark Melissa D Implement for use with a cleaning sheet
EP1744767A2 (en) * 2004-04-20 2007-01-24 The University of Chicago Therapeutic delivery system comprising a high molecular weight peg-like compound
US20070037721A1 (en) * 2004-09-01 2007-02-15 The Procter & Gamble Company Moistened disposable wipe for controlling allergens
US20090088705A1 (en) * 2007-10-02 2009-04-02 Sirkin Neil Application system for topically applied compositions

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997458A (en) * 1974-04-12 1976-12-14 Deknatel, Incorporated Method of cleansing contaminated wounds and surgical scrub solutions for same
SE7713618L (en) * 1977-12-01 1979-06-02 Astra Laekemedel Ab LOCAL ANESTHETIC MIXTURE
US4252286A (en) * 1979-04-16 1981-02-24 The Boeing Company Simplified core flow thrust control device
US4241048A (en) * 1979-05-01 1980-12-23 Bristol-Myers Company Suspension composition of benzocaine
US4330551A (en) * 1980-08-26 1982-05-18 Synergetics Co. Therapeutic method
GB2133284A (en) * 1983-01-07 1984-07-25 English Grains Limited Resilient pharmaceutical unit for treating mouth ulcers
AU5744490A (en) * 1989-05-15 1990-12-18 Afferon Corporation Composition and method for neural desensitization
US5811078A (en) * 1997-03-14 1998-09-22 Adolor Corporation Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions therewith
US5798093A (en) * 1997-03-14 1998-08-25 Adolor Corporation Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1353954A (en) * 1920-09-28 Combined towel and antiseptic pad
US2379657A (en) * 1942-08-22 1945-07-03 Ryco Lab Inc Package
US2689814A (en) * 1951-04-05 1954-09-21 Miles Lab Anesthetic and fungicidal chlorothymol composition and solution thereof
US2702780A (en) * 1950-10-10 1955-02-22 Phil Kalech Measuring dispensing sheet for germicides and process of forming same
US2801201A (en) * 1953-04-09 1957-07-30 Lincoln Lab Inc Burn treatment filling for pressure packaged dispenser
US2921885A (en) * 1955-11-25 1960-01-19 Colgate Palmolive Co Antibacterial composition
US2999265A (en) * 1957-09-23 1961-09-12 Dorothy B Tarnoff Saturated pad for cleansing and deodorizing
US3138533A (en) * 1958-05-27 1964-06-23 Leo J Heim Sanitary tissues
US3264188A (en) * 1963-01-16 1966-08-02 Kimberly Clark Co Sanitary impregnated skin wiper
US3283357A (en) * 1964-10-06 1966-11-08 Michigan Tool Co Disinfecting cleansing pad
US3539520A (en) * 1967-07-12 1970-11-10 West Laboratories Inc Compositions comprising quaternary ammonium germicides and nonionic surfactants

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1353954A (en) * 1920-09-28 Combined towel and antiseptic pad
US2379657A (en) * 1942-08-22 1945-07-03 Ryco Lab Inc Package
US2702780A (en) * 1950-10-10 1955-02-22 Phil Kalech Measuring dispensing sheet for germicides and process of forming same
US2689814A (en) * 1951-04-05 1954-09-21 Miles Lab Anesthetic and fungicidal chlorothymol composition and solution thereof
US2801201A (en) * 1953-04-09 1957-07-30 Lincoln Lab Inc Burn treatment filling for pressure packaged dispenser
US2921885A (en) * 1955-11-25 1960-01-19 Colgate Palmolive Co Antibacterial composition
US2999265A (en) * 1957-09-23 1961-09-12 Dorothy B Tarnoff Saturated pad for cleansing and deodorizing
US3138533A (en) * 1958-05-27 1964-06-23 Leo J Heim Sanitary tissues
US3264188A (en) * 1963-01-16 1966-08-02 Kimberly Clark Co Sanitary impregnated skin wiper
US3283357A (en) * 1964-10-06 1966-11-08 Michigan Tool Co Disinfecting cleansing pad
US3539520A (en) * 1967-07-12 1970-11-10 West Laboratories Inc Compositions comprising quaternary ammonium germicides and nonionic surfactants

Cited By (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3814095A (en) * 1972-03-24 1974-06-04 H Lubens Occlusively applied anesthetic patch
US3902559A (en) * 1972-06-29 1975-09-02 Water Jel Int Pty Ltd Fire fighting appliances
US4307143A (en) * 1977-10-17 1981-12-22 Kimberly-Clark Corporation Microfiber oil and water pipe
USRE31885E (en) * 1977-10-17 1985-05-14 Kimberly-Clark Corporation Microfiber oil and water wipe
US4340043A (en) * 1978-11-17 1982-07-20 Smith & Nephew Research Ltd. Adhesive-coated sheet material incorporating anti-bacterial substances
US4460369A (en) * 1978-11-17 1984-07-17 Smith & Nephew Research Ltd. Adhesive-coated sheet material incorporating anti-bacterial substances
US4321277A (en) * 1978-12-04 1982-03-23 Research Lab Products, Inc. Germicidal use of compositions containing certain quaternary ammonium compounds
US4259103A (en) * 1979-03-12 1981-03-31 Dow Corning Corporation Method of reducing the number of microorganisms in a media and a method of preservation
US4464293A (en) * 1982-04-12 1984-08-07 Dobrin Robert J Liquid cleaner-disinfectant composition for use in wiping down dental operatories
US4746509A (en) * 1983-03-24 1988-05-24 Rhone-Poulenc Sante Transdermal medicament
US4721511A (en) * 1984-10-05 1988-01-26 W. R. Grace & Co. Leach resistant antimicrobial fabric
US4834076A (en) * 1985-04-17 1989-05-30 Millet Jean M Device for treating the external human epithelium, process for its manufacture and process for using such a device
US4692374A (en) * 1985-09-05 1987-09-08 James River Corporation Antimicrobially active, non-woven web used in a wet wiper
US4615937A (en) * 1985-09-05 1986-10-07 The James River Corporation Antimicrobially active, non-woven web used in a wet wiper
US4737405A (en) * 1985-09-30 1988-04-12 James River Corporation Binder catalyst for an antimicrobially active, non-woven web
US4740398A (en) * 1985-09-30 1988-04-26 James River Corporation Binder catalyst for an antimicrobially active, non-woven web
US4781974A (en) * 1986-04-23 1988-11-01 James River Corporation Antimicrobially active wet wiper
US4732797A (en) * 1987-02-27 1988-03-22 James River Corporation Wet wiper natural acid preservation system
US5013769A (en) * 1988-08-22 1991-05-07 Medipro Sciences Limited Method of making a hydrogel-forming wound dressing or skin coating material
US4920158A (en) * 1989-10-11 1990-04-24 Medipro Sciences Limited Hydrogel-forming wound dressing or skin coating material
US5286538A (en) * 1991-08-05 1994-02-15 Leonard Pearlstein Disposable container for moist paper towels the same
US5409747A (en) * 1991-08-05 1995-04-25 Leonard Pearlstein Disposable container for moist paper towels and a method of making the same
US5540962A (en) * 1992-10-16 1996-07-30 Leonard Pearlstein Degradable package for containment of liquids
US5512333A (en) * 1992-10-16 1996-04-30 Icd Industries Method of making and using a degradable package for containment of liquids
US5458933A (en) * 1992-10-16 1995-10-17 Leonard Pearlstein Compostable packaging for containment of liquids
AU715706B2 (en) * 1996-01-05 2000-02-10 Reckitt Benckiser Healthcare (Uk) Limited Antiseptic composition containing a quaternary ammonium compound a chelating agent and a polyol
EP0954312A1 (en) * 1996-08-12 1999-11-10 Bruce Miller Topical composition for burn healing
EP0954312A4 (en) * 1996-08-12 1999-12-01
US5895504A (en) * 1997-07-09 1999-04-20 S. C. Johnson & Son, Inc. Methods for using a fabric wipe
WO2000050004A2 (en) * 1999-02-23 2000-08-31 Ioteck, Inc. Surgical anesthesia delivery system
WO2000050004A3 (en) * 1999-02-23 2001-09-07 Ioteck Inc Surgical anesthesia delivery system
US6364862B1 (en) * 1999-09-17 2002-04-02 Daniel Bonilla Single pad for providing both an anesthetic and an antiseptic for an injection site
US6986897B1 (en) 1999-10-04 2006-01-17 Johnson & Johnson Consumer Companies, Inc. Alcohol-free anti-bacterial wipes
US7169262B2 (en) 2000-12-22 2007-01-30 Vibre-Tech Llc Method and apparatus for forming a paper or tissue web
US6702925B2 (en) 2000-12-22 2004-03-09 Vibre-Tech Llc Method and apparatus for forming a paper or tissue web
US20040149415A1 (en) * 2000-12-22 2004-08-05 Vibre-Tech Llc Method and apparatus for forming a paper or tissue web
US20040140077A1 (en) * 2001-12-21 2004-07-22 Bricco Michael J. Method and apparatus for forming a paper or tissue web
US7101462B2 (en) 2001-12-21 2006-09-05 Vibre-Tech, Llc Method and apparatus for forming a paper or tissue web
US20070068644A1 (en) * 2001-12-21 2007-03-29 Vibre-Tech, Llc. Method and apparatus for forming a paper or tissue web
WO2004019682A1 (en) * 2002-08-28 2004-03-11 Luis Buil Torres Pharmaceutical composition for the treatment of viral, fungal and bacterial infections and applications of same
US20030165403A1 (en) * 2003-03-12 2003-09-04 Marsden James L. Decontamination of surface exposed to biological warfare agents
EP1744767A4 (en) * 2004-04-20 2008-08-13 Univ Chicago Therapeutic delivery system comprising a high molecular weight peg-like compound
EP1744767A2 (en) * 2004-04-20 2007-01-24 The University of Chicago Therapeutic delivery system comprising a high molecular weight peg-like compound
US20080206188A1 (en) * 2004-04-20 2008-08-28 Alverdy John C Therapeutic Delivery System Comprising a High Molecular Weight Peg-Like Compound
US20060277706A1 (en) * 2004-09-01 2006-12-14 Clark Melissa D Implement for use with a cleaning sheet
US20070037721A1 (en) * 2004-09-01 2007-02-15 The Procter & Gamble Company Moistened disposable wipe for controlling allergens
US20060276356A1 (en) * 2004-09-01 2006-12-07 Global General Premoistened wipe
US20060052269A1 (en) * 2004-09-01 2006-03-09 Panandiker Rajan K Premoistened disposable wipe
US7947086B2 (en) 2004-09-01 2011-05-24 The Procter & Gamble Company Method for cleaning household fabric-based surface with premoistened wipe
US20090088705A1 (en) * 2007-10-02 2009-04-02 Sirkin Neil Application system for topically applied compositions

Also Published As

Publication number Publication date
AT316739B (en) 1974-07-25
DE2031889A1 (en) 1971-07-15
US3730960A (en) 1973-05-01
CA949451A (en) 1974-06-18
BE752620A (en) 1970-12-28
GB1300588A (en) 1972-12-20

Similar Documents

Publication Publication Date Title
US3624224A (en) Novel first aid products
AU586243B2 (en) Antiseptic film forming fluids
JP5215514B2 (en) System for vibratory delivery of anti-infective compositions
US3249109A (en) Topical dressing
CA2702830C (en) Topical glycopyrrolate formulations
TWI428122B (en) Topical patch cooling preparation and methods for using the same
KR20020064978A (en) Antimicrobial Absorbent Article, and Methods of Making and Using the Same
KR970705976A (en) USE AND COMPOSITION OF AN ANTI-SEXUALLY TRANSMITTED DISEASES FORMULATION
US20220143077A1 (en) Antimicrobial and cleansing composition
JP2019531331A (en) Emollient topical disinfectant
US6387384B1 (en) Disinfectants to eradicate viral diseases such as HIV and Hepatitis
JP2904917B2 (en) Non-toxic, non-corrosive, biodegradable disinfectants and disinfectants
US7790771B1 (en) Use of tosylchloramide(s) for treating disease of the skin, mucous membrane, organs and tissues
JPH06102604B2 (en) Disinfectant
JPH0449229A (en) Composition for cutis
IL34659A (en) An antiseptic composition comprising a germicidal quaternary ammonium compound,a poly(oxyethylene)-poly(oxypropylene)-block polymer and a local anaesthetic
JPS63109865A (en) Pullulan film preparation containing drug as effective component
RU2171694C1 (en) Medical product
WO2001000254A1 (en) Absorbent articles of personal hygiene with therapeutic effect
US20240041756A1 (en) Disinfecting composition, applicator, and method of disinfecting
CN117618350A (en) Preparation method of rapid film forming dry powder suspension disinfection aerosol
JPS632931B2 (en)
JP2002145762A (en) Wet tissue-type liniment, packaged wet tissue-type liniment and method for applying
JPS6219869B2 (en)
Hollander et al. Clinical investigation of bentonite-petrolatum ointments and ointment bases